Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|September 27, 2021
HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector FunctionSimone I Richardson, Frances Ayres, Nelia P Manamela, et al.
Scientific Reports|October 1, 2022
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanismsThandeka Moyo-Gwete, Cathrine Scheepers, Zanele Makhado, et al.
Iscience|July 31, 2025
SARS-CoV-2 vaccines elicit differential Fc effector functionsNelia P Manamela, Boitumelo M Motsoeneng, Holly Spencer, et al.
Scientific Reports|June 10, 2024
Evaluating the antibody response elicited by diverse HIV envelope immunogens in the African green monkey (Vervet) modelThandeka Moyo-Gwete, Frances Ayres, Nonkululeko B Mzindle, et al.
Journal of Virology|December 12, 2023
Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccinesMatthew J Vukovich, Nagarajan Raju, Prudence Kgagudi, et al.
Frontiers in Immunology|August 21, 2023
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccinationBoitumelo M Motsoeneng, Nelia P Manamela, Haajira Kaldine, et al.
Journal of Virology|July 22, 2022
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus VariantsThandeka Moyo-Gwete, Mashudu Madzivhandila, Nonhlanhla N Mkhize, et al.
Cell Reports. Medicine|March 2, 2022
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivitySimone I Richardson, Nelia P Manamela, Boitumelo M Motsoeneng, et al.
Clinical Immunology (Orlando, Fla.)|December 23, 2023
Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell responseClaire Butters, Ntombi Benede, Thandeka Moyo-Gwete, et al.
Journal of Virology|July 2, 2024
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunitySimone I Richardson, Nonkululeko Mzindle, Thopisang Motlou, et al.
Pageof 3